Murae Organisor Limited

Equities

EARUM

INE060601023

Pharmaceuticals

Market Closed - Bombay S.E. 08:00:41 18/05/2024 BST 5-day change 1st Jan Change
1.72 INR +4.24% Intraday chart for Murae Organisor Limited +18.62% +49.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Murae Organisor Limited Announces Board Appointments CI
Murae Organisor Limited Appoints Sangita Rajpurohit as Company Secretary and Compliance Officer CI
Earum Pharmaceuticals Limited Approves Board Resignations CI
Earum Pharmaceuticals' CFO Resigns MT
Earum Pharmaceuticals Limited Announces Resignation of Sunil Kumar Patel as Chief Financial Officer CI
Earum Pharmaceuticals Limited Approves Appointment of Vaghasiya Brijeshkumar Mathurbhai as Chief Financial Officer CI
Earum Pharmaceuticals Limited Announces Change in Corporate Office Address CI
Earum Pharmaceuticals Limited Announces Resignation of Sanjaykumar Nai as Non-Executive Director CI
Earum Pharmaceuticals Limited Announces Resignation of Vijaykumar Patel as Managing Director CI
Murae Organisor Names Managing Director MT
Earum Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Earum Pharmaceuticals Limited Approves Board Changes CI
Earum Pharmaceuticals Names CFO MT
Earum Pharmaceuticals Limited Appoints Sunilkumar Patel as Chief Financial Officer CI
Earum Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Earum Pharmaceuticals CFO Departs MT
Earum Pharmaceuticals Limited Announces Executive Changes CI
Earum Pharmaceuticals Limited Announces Change of Registered Office CI
Payal Patel Resigns as Chief Financial Officer of Earum Pharmaceuticals Limited CI
Earum Pharmaceuticals Limited Announces Resignation of Directors CI
Earum Pharmaceuticals Limited Announces Resignation of Madhuri Mistry from the Position of the Company Secretary CI
Earum Pharmaceuticals Limited's Board intends to launch an Equity Buyback on July 14, 2023 CI
Earum Pharmaceuticals Plans to Open Three Overseas Branches MT
E Earum Pharmaceuticals Limited Approves the Proposal for Opening of Three Overseas Branch Offices CI
Earum Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Chart Murae Organisor Limited
More charts
Murae Organisor Limited, formerly Earum Pharmaceuticals Limited, is an India-based pharmaceutical company. The Company is primarily engaged in marketing, trading and distribution of a range of pharmaceutical formulation products, such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/ anti-pyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by it under its own brand name. It also deals in the trading of active pharmaceutical ingredients (API’s). Its products include HYGNEX+, HYGNEX+ Spray, EROLON and HYGNEX. It carries its business operations in Indian States, such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan and others.
More about the company